12th Apr 2013 17:11
Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
I give below details of changes in the interests of Directors or Persons Discharging Managerial Responsibility in the Ordinary Shares of GlaxoSmithKline plc in respect of the under-mentioned persons arising from the purchase of Ordinary Shares at a price of 1560.192 pence per Ordinary Share on 11 April 2013 as a result of the reinvestment of dividends paid on Ordinary Shares held in the GlaxoSmithKline ShareReward Plan (the Plan).
Sir Andrew Witty | Acquisition of 31 Ordinary Shares
|
Mr S Dingemans | Acquisition of 6 Ordinary Shares
|
Mr S M Bicknell | Acquisition of 46 Ordinary Shares
|
Mr R G Connor | Acquisition of 39 Ordinary Shares
|
Mr S A Hussain | Acquisition of 8 Ordinary Shares
|
Mr D S Redfern | Acquisition of 46 Ordinary Shares
|
Ms C Thomas | Acquisition of 46 Ordinary Shares
|
Mr P C Thomson | Acquisition of 20 Ordinary Shares
|
Dr P J T Vallance | Acquisition of 24 Ordinary Shares |
Ms E Walmsley | Acquisition of 2 Ordinary Shares |
Mrs V A Whyte | Acquisition of 30 Ordinary Shares |
The Company and the above-mentioned persons were advised of this information on
12 April 2013.
This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Company Secretary
12 April 2013
Related Shares:
Glaxosmithkline